Works matching IS 13657852 AND DT 2011 AND VI 14 AND IP 3
Results: 14
XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 225, doi. 10.1038/pcan.2011.26
- By:
- Publication type:
- Article
Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 262, doi. 10.1038/pcan.2011.18
- By:
- Publication type:
- Article
Outcomes of extremely low risk prostate cancer following radical prostatectomy.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 266, doi. 10.1038/pcan.2011.21
- By:
- Publication type:
- Article
Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 238, doi. 10.1038/pcan.2011.10
- By:
- Publication type:
- Article
Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 219, doi. 10.1038/pcan.2011.25
- By:
- Publication type:
- Article
Local insulin-like growth factor-I of ventral prostate was upregulated during long-term castration and may function through the autocrine system.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 248, doi. 10.1038/pcan.2011.14
- By:
- Publication type:
- Article
Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 232, doi. 10.1038/pcan.2011.9
- By:
- Publication type:
- Article
Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 253, doi. 10.1038/pcan.2011.16
- By:
- Publication type:
- Article
Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 270, doi. 10.1038/pcan.2011.27
- By:
- Publication type:
- Article
Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 192, doi. 10.1038/pcan.2011.23
- By:
- Publication type:
- Article
National-wide data on the treatment of BPH in Korea.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 243, doi. 10.1038/pcan.2011.12
- By:
- Publication type:
- Article
Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 206, doi. 10.1038/pcan.2011.24
- By:
- Publication type:
- Article
Editor's comments.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2011, v. 14, n. 3, p. 191, doi. 10.1038/pcan.2011.39
- By:
- Publication type:
- Article